Cargando…

Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?

COSYCONET 1 is the only German COPD cohort which is large enough to be internationally comparable. The recruitment, which started in 2010 and ended in December 2013, comprised 2741 patients with the diagnosis of COPD who were subsequently investigated in regular follow-up visits. All visits included...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahnert, Kathrin, Fischer, Carolina, Alter, Peter, Trudzinski, Franziska, Welte, Tobias, Behr, Jürgen, Herth, Felix, Kauczor, Hans-Ulrich, Bals, Robert, Watz, Henrik, Rabe, Klaus, Söhler, Sandra, Kokot, Inge, Vogelmeier, Claus, Jörres, Rudolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931494/
https://www.ncbi.nlm.nih.gov/pubmed/36526266
http://dx.doi.org/10.1055/a-1966-0848
_version_ 1784889262343192576
author Kahnert, Kathrin
Fischer, Carolina
Alter, Peter
Trudzinski, Franziska
Welte, Tobias
Behr, Jürgen
Herth, Felix
Kauczor, Hans-Ulrich
Bals, Robert
Watz, Henrik
Rabe, Klaus
Söhler, Sandra
Kokot, Inge
Vogelmeier, Claus
Jörres, Rudolf
author_facet Kahnert, Kathrin
Fischer, Carolina
Alter, Peter
Trudzinski, Franziska
Welte, Tobias
Behr, Jürgen
Herth, Felix
Kauczor, Hans-Ulrich
Bals, Robert
Watz, Henrik
Rabe, Klaus
Söhler, Sandra
Kokot, Inge
Vogelmeier, Claus
Jörres, Rudolf
author_sort Kahnert, Kathrin
collection PubMed
description COSYCONET 1 is the only German COPD cohort which is large enough to be internationally comparable. The recruitment, which started in 2010 and ended in December 2013, comprised 2741 patients with the diagnosis of COPD who were subsequently investigated in regular follow-up visits. All visits included a comprehensive functional and clinical characterisation. On the basis of this detailed data set, it was possible to address a large number of clinical questions. These questions ranged from the prescription of medication, the detailed analysis of comorbidities, in particular cardiovascular disease, and biomarker assessment to radiological and health-economic aspects. Currently, more than 60 publications of COSYCONET data are internationally available. The present overview provides a description of all the results that were obtained, focussing on the relationship between different clinical and functional aspects as well as their potential practical consequences. In addition, information on the follow-up study COSYCONET 2 is given.
format Online
Article
Text
id pubmed-9931494
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-99314942023-02-16 Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter? Kahnert, Kathrin Fischer, Carolina Alter, Peter Trudzinski, Franziska Welte, Tobias Behr, Jürgen Herth, Felix Kauczor, Hans-Ulrich Bals, Robert Watz, Henrik Rabe, Klaus Söhler, Sandra Kokot, Inge Vogelmeier, Claus Jörres, Rudolf Pneumologie COSYCONET 1 is the only German COPD cohort which is large enough to be internationally comparable. The recruitment, which started in 2010 and ended in December 2013, comprised 2741 patients with the diagnosis of COPD who were subsequently investigated in regular follow-up visits. All visits included a comprehensive functional and clinical characterisation. On the basis of this detailed data set, it was possible to address a large number of clinical questions. These questions ranged from the prescription of medication, the detailed analysis of comorbidities, in particular cardiovascular disease, and biomarker assessment to radiological and health-economic aspects. Currently, more than 60 publications of COSYCONET data are internationally available. The present overview provides a description of all the results that were obtained, focussing on the relationship between different clinical and functional aspects as well as their potential practical consequences. In addition, information on the follow-up study COSYCONET 2 is given. Georg Thieme Verlag KG 2022-12-16 /pmc/articles/PMC9931494/ /pubmed/36526266 http://dx.doi.org/10.1055/a-1966-0848 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Kahnert, Kathrin
Fischer, Carolina
Alter, Peter
Trudzinski, Franziska
Welte, Tobias
Behr, Jürgen
Herth, Felix
Kauczor, Hans-Ulrich
Bals, Robert
Watz, Henrik
Rabe, Klaus
Söhler, Sandra
Kokot, Inge
Vogelmeier, Claus
Jörres, Rudolf
Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?
title Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?
title_full Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?
title_fullStr Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?
title_full_unstemmed Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?
title_short Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?
title_sort was haben wir aus der deutschen copd-kohorte cosyconet gelernt und wie geht es weiter?
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931494/
https://www.ncbi.nlm.nih.gov/pubmed/36526266
http://dx.doi.org/10.1055/a-1966-0848
work_keys_str_mv AT kahnertkathrin washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter
AT fischercarolina washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter
AT alterpeter washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter
AT trudzinskifranziska washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter
AT weltetobias washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter
AT behrjurgen washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter
AT herthfelix washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter
AT kauczorhansulrich washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter
AT balsrobert washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter
AT watzhenrik washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter
AT rabeklaus washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter
AT sohlersandra washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter
AT kokotinge washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter
AT vogelmeierclaus washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter
AT jorresrudolf washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter